“บิต บราเดอร์” เตรียมยื่นอุทธรณ์กรณีคำตัดสินเพิกถอนหลักทรัพย์โดยคณะกรรมการพิจารณาตลาดหุ้น Nasdaqby March 12, 2024PR Newswire
DITP and Board of Trade of Thailand collaborate for STYLE Bangkok 2024, showcasing Thai heritage and boosting SMEs’ sustainabilityby March 12, 2024PR Newswire
Baseus Introduces a Revolutionary Open-Ear Experience with Eli Sport 1 Open-Ear TWS Earbudsby March 12, 2024PR Newswire
TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovationby March 12, 2024PR Newswire
Toyota Finance Corporation implements Wolters Kluwer’s CCH Tagetik CPM solutionby March 12, 2024PR Newswire
MAXHUB เปิดตัวกระดานอัจฉริยะเพื่อการศึกษารุ่นใหม่ “U3 Series” รับรองโดย Google EDLAby March 12, 2024PR Newswire
Mowilex Provides Interior and Exterior Paint for Pioneering Bali International Hospitalby March 12, 2024PR Newswire
Monoova appoints new CCO and General Counsel as demand for digital payments set to soarby March 12, 2024PR Newswire
BuildTech Asia 2024 advances regional collaboration, professional development and knowledge to future-proof Built Sectorby March 12, 2024PR Newswire
Auction house im Kinsky: Auction of the year with Klimt’s “Portrait of Fräulein Lieser”: Live feed and news feed offers for TV and online streamingby March 12, 2024PR Newswire
FETC International Showcases Cutting-Edge MLFF ETC Solutions at 2024 Smart City Summit and Expoby March 12, 2024PR Newswire
PROMISE Technology’s Leading RAID Storage Solutions for Rich Media Now Available in Middle East & South Koreaby March 12, 2024PR Newswire
Rently Expands As The First Deposit-Free Multi-Industry Rental Platform in Singapore in Collaboration with The Working Capitol and Smart City Kitchensby March 12, 2024PR Newswire
Acclime announces expansion into UAE with acquisition and rebranding of MeiProby March 12, 2024PR Newswire
Casio to Release Uterocervical Observation Camera in the United States, Australia and New Zealandby March 12, 2024PR Newswire
Everest Medicines’ Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®by March 12, 2024PR Newswire
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canadaby March 12, 2024PR Newswire
